Abdominal Massage for Chemotherapy-Induced Constipation

Prevention of Constipation in Cancer Patients

Recruiting N/A Interventional Study
Constipation Drug Induced
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
146 (estimated)
Sponsor
Marmara University · Other
Who this trial is looking for

This trial is looking for adults with breast or lung cancer who are experiencing constipation from chemotherapy. Participants will be involved in treatments that aim to reduce constipation symptoms.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years of age or older
  • I am receiving chemotherapy for breast cancer or lung cancer
  • I have had at least one cycle of chemotherapy
  • I have experienced constipation related to chemotherapy in the last five days
  • I can read and write and am willing to take part
  • I do not have a psychiatric illness
  • I do not have an abdominal obstruction
  • I do not have any mass in my abdominal region

You may not be able to join if

  • I have stool type 3, 4, 5, 6, or 7 according to the Bristol Stool Scale
  • I have intestinal bleeding
  • I have had radiation therapy to my abdominal region
  • I have had surgical procedures in my abdominal region
  • I have an intra-abdominal infection
  • I have inflammatory bowel disease
  • I have irritable bowel syndrome

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Constipation is the third most common symptom in patients undergoing chemotherapy, with an incidence rate ranging from 31% to 90%. Despite its high prevalence and adverse effects on patients, constipation is often not reported by patients and is not frequently monitored by nurses, resulting in delays in treatment and care. Prolonged constipation can lead to health problems such as fecal impaction/…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years of age or older, * Receiving chemotherapy for breast cancer or lung cancer that causes constipation * Patients who received at least one cycle of chemotherapy and experienced chemotherapy-associated constipation within five days of treatment (stool type 1 or 2 accordi…
Contacts

CAN LAFÇI, PhD(c)

+90 546 931 90 39

can.lafci@ogr.iuc.edu.tr

CONTACT

Gülbeyaz CAN, PhD

+90 532 626 49 69

gulbeyaz@istanbul.edu.tr

CONTACT